Jackson Acquisition II (JACS.U) priced its SPAC IPO in sync with the terms in its prospectus – 20.0 million units at $10.00 each – and raised $200 million on Monday night, Dec. 9, 2024. Each unit consists of one share of common stock and one right to receive one-tenth (1/10th) of a share of common stock upon completion of an initial business combination.
Jackson Acquisition II opened at $10.02, touched an intraday high at $10.03, and dipped back to $10.02 in its debut today – Tuesday, Dec. 10, 2024 – on the New York Stock Exchange. Volume was about 1.94 million shares.
The company, based in Alpharetta, Georgia, intends to search for target companies in the healthcare sector, according to the prospectus.
Richard Jackson, the CEO and chairman of Jackson Acquisition II, is the chairman and CEO of Jackson Healthcare, a healthcare staffing company.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Disclaimer: A SCOOP Rating (Wall Street Consensus of Opening-day Premiums) is a general consensus taken, at press time, from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. The SCOOP Rating does not reflect the opinions of anyone associated with IPOScoop.com. The SCOOP ratings should not be taken as investment advice. The rating merely reflects the opinion of the professionals at the time of publication and is subject to last-minute changes due to market conditions, changes in a specific offering and other factors, such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from sources we believe to be reliable, but we cannot guarantee the accuracy.